SMTL ID : 5wr7.1

Crystal structure of Trk-A complexed with a selective inhibitor CH7057288

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.76 Å

Oligo State

monomer

Ligands

1 x RCH: N-tert-butyl-2-[2-[6,6-dimethyl-8-(methylsulfonylamino)-11-oxidanylidene-naphtho[2,3-b][1]benzofuran-3-yl]ethynyl]-6-methyl-pyridine-4-carboxamide(Non-covalent)

RCH.1: 24 residues within 4Å: Chain A: L.28, V.36, A.54, K.56, E.72, L.76, L.79, I.84, V.85, F.101, E.102, Y.103, M.104, R.105, H.106, G.107, D.108, F.158, H.160, L.169, I.178, G.179, D.180, F.181 21 PLIP interactions: 21 interactions with chain A Hydrophobic interactions: A:L.28, A:L.28, A:L.28, A:V.36, A:A.54, A:E.72, A:L.79, A:I.84, A:V.85, A:V.85, A:F.101, A:F.101, A:F.101, A:F.101, A:Y.103, A:F.158, A:L.169, A:I.178, A:D.180, A:F.181 Hydrogen bonds: A:M.104

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tanaka, H. et al., Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer. Mol. Cancer Ther. (2018)

Release Date

2017-12-06

Peptides

High affinity nerve growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

High affinity nerve growth factor receptor